← Reviews
Open accessJun 27, 2026

Gut microbiota–enteric nervous system axis: from bidirectional programming to precision therapeutics in digestive diseases

No abstract available; no empirical data can be extracted or analyzed.

Evidence levelDNarrative / animal / in vitro / mechanistic
Study typenarrative_review
Sample
Effect directionInsufficient
CertaintyVery low
Clinical applicabilityVery low
Overinterpretation risk1/5 · Low
PICO
Population
Intervention
Comparator
Outcome

What the study showed

The title suggests a narrative or theoretical review on bidirectional communication between gut microbiota and the enteric nervous system in digestive diseases. No abstract is available to verify findings, study population, or authors' conclusions.

How it was done

Study type cannot be verified from available information. The phrase 'precision therapeutics' in the title may indicate a literature review or conceptual proposal.

Risk of bias

Complete absence of an abstract prevents any methodological assessment. The evidence grade assigned is the most conservative possible due to lack of data.

Interpretation limit

What this study does NOT prove

Nothing can be concluded about the efficacy, safety, or clinical applicability of any intervention.

In clinical practice

No clinical recommendation can be derived from this record. A title alone does not constitute evidence.

Limitations

Complete absence of an abstract prevents any methodological assessment. The evidence grade assigned is the most conservative possible due to lack of data.

Technical appendix

Version history

  • 1.0 · 2026-06-27 — Auto-generated under Evidence Standard v1.0

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.